Global Patent Index - EP 3600393 A1

EP 3600393 A1 20200205 - COMBINATION THERAPY FOR THE TREATMENT OF SOLID AND HEMATOLOGICAL CANCERS

Title (en)

COMBINATION THERAPY FOR THE TREATMENT OF SOLID AND HEMATOLOGICAL CANCERS

Title (de)

KOMBINATIONSTHERAPIE ZUR BEHANDLUNG VON SOLIDEN UND HÄMATOLOGISCHEN BÖSARTIGEN TUMOREN

Title (fr)

POLYTHÉRAPIE POUR LE TRAITEMENT DE CANCERS SOLIDES ET HÉMATOLOGIQUES

Publication

EP 3600393 A1 20200205 (EN)

Application

EP 18771103 A 20180322

Priority

  • US 201762475036 P 20170322
  • US 201762475032 P 20170322
  • US 201815871802 A 20180115
  • US 2018023860 W 20180322

Abstract (en)

[origin: WO2018175790A1] Methods are provided for using anti-CD47 mAbs as therapeutics for the prevention and treatment of solid and hematological cancers, with other anti-cancer agents, more specifically, chemotherapeutic agents, which include but are not limited to anthracyclines, platinums, taxols, topisomerase inhibitors, anti-metabolites, anti-tumor antibiotics, mitotic inhibitors, and alkylating agents.

IPC 8 full level

A61K 39/00 (2006.01); A61K 39/395 (2006.01); A61K 41/00 (2020.01)

CPC (source: EP US)

A61K 31/704 (2013.01 - EP US); A61K 39/3955 (2013.01 - EP US); A61K 45/06 (2013.01 - EP US); A61P 1/00 (2018.01 - EP US); A61P 3/10 (2018.01 - EP US); A61P 5/38 (2018.01 - EP US); A61P 7/06 (2018.01 - EP US); A61P 9/00 (2018.01 - EP US); A61P 9/10 (2018.01 - EP US); A61P 17/06 (2018.01 - EP US); A61P 19/02 (2018.01 - EP US); A61P 21/04 (2018.01 - EP US); A61P 25/28 (2018.01 - EP US); A61P 35/00 (2018.01 - EP US); A61P 35/02 (2018.01 - EP US); A61P 37/02 (2018.01 - EP US); C07K 16/2803 (2013.01 - EP US); A61K 2039/505 (2013.01 - EP US); C07K 2317/24 (2013.01 - EP US); C07K 2317/33 (2013.01 - EP US); C07K 2317/41 (2013.01 - EP US); C07K 2317/526 (2013.01 - EP US); C07K 2317/53 (2013.01 - EP US); C07K 2317/55 (2013.01 - EP US); C07K 2317/56 (2013.01 - US); C07K 2317/565 (2013.01 - US); C07K 2317/70 (2013.01 - EP US); C07K 2317/71 (2013.01 - EP US); C07K 2317/73 (2013.01 - EP US); C07K 2317/732 (2013.01 - US); C07K 2317/734 (2013.01 - US); C07K 2317/76 (2013.01 - EP US); C07K 2317/92 (2013.01 - EP US)

C-Set (source: EP US)

  1. A61K 31/704 + A61K 31/704 + A61K 2300/00 + A61K 2300/00
  2. A61K 39/3955 + A61K 39/3955 + A61K 2300/00 + A61K 2300/00

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

Designated extension state (EPC)

BA ME

DOCDB simple family (publication)

WO 2018175790 A1 20180927; AU 2018240377 A1 20191031; CA 3057139 A1 20180927; CN 111148535 A 20200512; EP 3600393 A1 20200205; EP 3600393 A4 20201223; JP 2020511481 A 20200416; SG 11201908602U A 20191030

DOCDB simple family (application)

US 2018023860 W 20180322; AU 2018240377 A 20180322; CA 3057139 A 20180322; CN 201880028490 A 20180322; EP 18771103 A 20180322; JP 2019551449 A 20180322; SG 11201908602U A 20180322